Hyderabad: Switzerland headquartered Ferring Pharma has announced the establishment of another formulation unit in India at Hyderabad for manufacturing of its product called Pentasa (Mesalazine). Ferring will invest approximately € 60 million (about Rs 500 crore) over the next 2-3 years for establishing this manufacturing facility. Pentasa is a Ferring product used for the treatment […]